We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Portable Air Filters Effectively Remove SARS-CoV-2 Particles from Hospital Air in COVID-19 Surge Units

By HospiMedica International staff writers
Posted on 04 Nov 2021
Print article
Image: Medi 10 UV-C Air Purifier (Photo courtesy of MAXVAC)
Image: Medi 10 UV-C Air Purifier (Photo courtesy of MAXVAC)

In the world’s first live study, researchers have demonstrated that using a combination of science and engineering, COVID-19 aerosols and other microbial bioaerosols can be removed from the environment.

The study by researchers at Addenbrooke’s Hospital (Cambridge, UK) confirmed the efficacy of MAXVAC’s (Zurich, Switzerland) Medi 10 range of COVID busting mobile air purifiers. The theory behind the science was accepted, that the Medi successfully traps & kills the COVID virus, but up until very recently, no published trials had been carried out with COVID itself (just lookalike viruses).

The key to the success of the Medi has been a combination of science and engineering. The science was to refine a sequence of filters and UV-C light that could trap and kill the virus. This was achieved with the development of high flow Alpaire HEPA filters and advanced Steribreeze UV-C technology to clean air fast. The engineering was to put this science in an effective compact and secure mobile unit that was easy to use and capable of maintaining the cleaning of very high volumes of air fast. High airflow rates are very important so that the recommended air change scan be achieved, and more air is cleaned of the virus.

“We have worked closely with a number of hospitals, universities, schools & councils in the past two years and are thrilled that our Medi units have received yet another endorsement especially from such a prestigious research hospital as Addenbrookes,” said Neil Parsons, MAXVAC UK representative. Our goal at MAXVAC remains to continue to find solutions to make our working & living environments safer, and the Medi’s are part of that journey.”

Related Links:
Addenbrooke’s Hospital
MAXVAC 

Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Critical Care Cart
Avalo
New
Intelligent Mattress System
DualPlus

Print article

Channels

Critical Care

view channel
Image: A mechanosensing-based approach offers a potential path to the treatment for cardiac fibrosis (Photo courtesy of Adobe Stock)

Mechanosensing-Based Approach Offers Promising Strategy to Treat Cardiovascular Fibrosis

Cardiac fibrosis, which involves the stiffening and scarring of heart tissue, is a fundamental feature of nearly every type of heart disease, from acute ischemic injuries to genetic cardiomyopathies.... Read more

Surgical Techniques

view channel
Image: Bioprinting synthetic vasculature could dramatically change how cardiovascular diseases are treated (Dell, A.C., Maresca, J., Davis, B.A. et al.; doi.org/10.1038/s41598-025-93276-y)

Bioprinted Aortas Offer New Hope for Vascular Repair

Current treatment options for severe cardiovascular diseases include using grafts made from a patient's own tissue (autologous) or synthetic materials. However, autologous grafts require invasive surgery... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more